Q4 Results: ABB India Profit Misses Estimates; Dr Reddy's Profit Beats; Bank Of India Profit Up 80%

India Shelter Finance Q4 FY25 Results Highlights (YoY)

• Total Income up 34% at Rs 327 crore versus Rs 244 crore

• Net profit up 39% at Rs 108 crore versus Rs 77.7 crore

Reliance Power Q4 Highlights (Consolidated, YoY)

• Revenue down 1% to Rs 1,978 crore versus Rs 1,997 crore

• Net Profit of Rs 125.6 crore versus loss of Rs 397 crore

• Ebitda up 217.2% to Rs 590 crore versus Rs 186 crore

• Margin at 29.8% versus 9.3%

Dr. Reddy's Labs outlined its plans and performance highlights. The company expects to launch Rituximab in the US in FY26 and plans to introduce 18-20 new products in North America during the same period.

Currently, it doesn't plan to set up a manufacturing unit in the US but is assessing the impact of proposed tariffs with customers. Domestic sales dropped 3% QoQ due to low sales in some brands, while gross margins fell 300 bps QoQ to 55.6% due to one-time costs.

The nicotine portfolio aided global generics growth and its integration in Europe is complete.

(Source: Earnings concall, Informist)

ABB India Q1CY25 Highlights (YoY)

• Revenue rose 2.6% to Rs 3,159.56 crore versus Rs 3,080.36 crore. (Estimate: Rs 3,428 crore)

• Ebitda up 3% to Rs 582.27 crore versus Rs 565.18 crore. (Estimate: Rs 621 crore)

• Margin at 18.4% versus 18.3% (Estimate: 18.1%)

• Net profit up 3.3% to Rs 474.63 crore versus Rs 459.29 crore. (Estimate: Rs 520 crore)

The board has recommended a dividend of Rs 14 per equity share for the financial year 2024-25, subject to the approval of the shareholders at the ensuing Annual General Meeting of the Company. The record date for payment of dividend is fixed as Friday, July 4, 2025